Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Black Diamond Therapeutics (BDTX) Other Working Capital Changes: 2019-2021

Historic Other Working Capital Changes for Black Diamond Therapeutics (BDTX) over the last 3 years, with Dec 2021 value amounting to -$3.9 million.

  • Black Diamond Therapeutics' Other Working Capital Changes fell 443.77% to -$3.9 million in Q4 2021 from the same period last year, while for Dec 2021 it was -$1.7 million, marking a year-over-year decrease of 150.16%. This contributed to the annual value of -$3.4 million for FY2024, which is 9.28% down from last year.
  • Per Black Diamond Therapeutics' latest filing, its Other Working Capital Changes stood at -$3.9 million for Q4 2021, which was down 390.29% from -$793,000 recorded in Q3 2021.
  • In the past 5 years, Black Diamond Therapeutics' Other Working Capital Changes registered a high of $3.8 million during Q1 2020, and its lowest value of -$3.9 million during Q4 2021.
  • For the 3-year period, Black Diamond Therapeutics' Other Working Capital Changes averaged around $228,167, with its median value being $59,500 (2019).
  • Data for Black Diamond Therapeutics' Other Working Capital Changes shows a peak YoY increase of 222.01% (in 2020) and a maximum YoY decrease of 1,150.00% (in 2020) over the last 5 years.
  • Over the past 3 years, Black Diamond Therapeutics' Other Working Capital Changes (Quarterly) stood at $754,000 in 2019, then skyrocketed by 50.00% to $1.1 million in 2020, then slumped by 443.77% to -$3.9 million in 2021.
  • Its last three reported values are -$3.9 million in Q4 2021, -$793,000 for Q3 2021, and $151,000 during Q2 2021.